{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:47:38Z","timestamp":1779324458735,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier","isbn-type":[{"value":"9780443193460","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.apcsb.2024.06.001","type":"book-chapter","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T19:49:32Z","timestamp":1720295372000},"page":"1-24","source":"Crossref","is-referenced-by-count":9,"title":["Unlocking estrogen receptor: Structural insights into agonists and antagonists for glioblastoma therapy"],"prefix":"10.1016","author":[{"given":"Asokan","family":"Madeshwaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Periyasamy","family":"Vijayalakshmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidhya Rekha","family":"Umapathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeshkumar","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrabose","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.apcsb.2024.06.001_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1259034","article-title":"The cross-talk between macrophages and tumor cells as a target for cancer treatment","volume":"13","author":"Aizaz","year":"2023","journal-title":"Frontiers in Oncology"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.06.001_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041620","article-title":"Immunohistochemical analysis of DNA repair- and drug-efflux-associated molecules in tumor and peritumor areas of glioblastoma","volume":"22","author":"Angelucci","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10.1016\/bs.apcsb.2024.06.001_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13111536","article-title":"Advances in glioblastoma therapy: An update on current approaches","volume":"13","author":"Angom","year":"2023","journal-title":"Brain Sciences"},{"issue":"18","key":"10.1016\/bs.apcsb.2024.06.001_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15184653","article-title":"Nuclear estrogen receptors in prostate cancer: From genes to function","volume":"15","author":"Belluti","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.06.001_bib5","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00204-024-03723-4","article-title":"The physiological and biochemical basis of potency thresholds modeled using human estrogen receptor alpha: Implications for identifying endocrine disruptors","volume":"98","author":"Borgert","year":"2024","journal-title":"Archives of Toxicology"},{"key":"10.1016\/bs.apcsb.2024.06.001_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jsbmb.2015.07.018","article-title":"Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells","volume":"161","author":"Chan","year":"2016","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/bs.apcsb.2024.06.001_bib7","article-title":"Role of estrogen receptors in health and disease","volume":"13","author":"Chen","year":"2022","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"issue":"1\u20132","key":"10.1016\/bs.apcsb.2024.06.001_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsbmb.2011.02.001","article-title":"Aromatase, aromatase inhibitors, and breast cancer","volume":"125","author":"Chumsri","year":"2011","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s12967-024-05269-6","article-title":"Estetrol\/GPER\/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells","volume":"22","author":"Cirillo","year":"2024","journal-title":"Journal of Translational Medicine"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.06.001_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14041092","article-title":"Glioblastoma microenvironment and cellular interactions","volume":"14","author":"Crivii","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.06.001_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10450","article-title":"Implications of regulatory T cells in anti-cancer immunity: From pathogenesis to therapeutics","volume":"8","author":"Dwivedi","year":"2022","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.06.001_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3892\/ol.2022.13632","article-title":"Molecular targeted therapy: A new avenue in glioblastoma treatment","volume":"25","author":"El Atat","year":"2023","journal-title":"Oncology Letters"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.06.001_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061189","article-title":"Drug delivery systems in the development of novel strategies for glioblastoma treatment","volume":"14","author":"El Kheir","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apcsb.2024.06.001_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.apcsb.2019.01.001","article-title":"Estrogen receptor signaling mechanisms","volume":"116","author":"Fuentes","year":"2019","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010111","article-title":"A review on a deep learning perspective in brain cancer classification","volume":"11","author":"Tandel","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.06.001_bib16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1102\/1470-7330.2013.0039","article-title":"Progress on the diagnosis and evaluation of brain tumors","volume":"13","author":"Gao","year":"2013","journal-title":"Cancer Imaging: the Official Publication of the International Cancer Imaging Society"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PPO.0b013e3182431c6f","article-title":"Antiangiogenic therapy for glioblastoma","volume":"18","author":"Gerstner","year":"2012","journal-title":"Cancer Journal (Sudbury, Mass.)"},{"issue":"7-S","key":"10.1016\/bs.apcsb.2024.06.001_bib18","first-page":"61","article-title":"Potential roads for reaching the summit: An overview on target therapies for high-grade gliomas","volume":"91","author":"Giotta Lucifero","year":"2020","journal-title":"Acta Bio-Medica: Atenei Parmensis"},{"issue":"22","key":"10.1016\/bs.apcsb.2024.06.001_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212404","article-title":"Estrogen receptors as molecular targets of endocrine therapy for glioblastoma","volume":"22","author":"Gonzalez-Mora","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3892\/ol.2022.13338","article-title":"Proliferation and apoptosis regulation by G protein-coupled estrogen receptor in glioblastoma C6 cells","volume":"24","author":"Gutierrez-Almeida","year":"2022","journal-title":"Oncology Letters"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib21","first-page":"3","article-title":"Glioblastoma multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment","volume":"18","author":"Hanif","year":"2017","journal-title":"Asian Pacific Journal of Cancer Prevention: APJCP"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.06.001_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11060-020-03467-y","article-title":"High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients","volume":"147","author":"Honikl","year":"2020","journal-title":"Journal of Neuro-oncology"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.06.001_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/bcr945","article-title":"Endocrinology and hormone therapy in breast cancer: Aromatase inhibitors versus antioestrogens","volume":"6","author":"Howell","year":"2004","journal-title":"Breast Cancer Research: BCR"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13046-020-01788-4","article-title":"The immunomodulatory effects of endocrine therapy in breast cancer","volume":"40","author":"Huang","year":"2021","journal-title":"Journal of Experimental & Clinical Cancer Research: CR"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.06.001_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202000054","article-title":"Lipid-based nanocarriers for the treatment of glioblastoma","volume":"1","author":"Iturrioz-Rodriguez","year":"2021","journal-title":"Advanced NanoBiomed Research"},{"issue":"10","key":"10.1016\/bs.apcsb.2024.06.001_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2176\/nmc.ra.2018-0141","article-title":"Potential strategies overcoming the temozolomide resistance for glioblastoma","volume":"58","author":"Jiapaer","year":"2018","journal-title":"Neurologia Medico-Chirurgica (Tokyo)"},{"issue":"18","key":"10.1016\/bs.apcsb.2024.06.001_bib27","article-title":"A review of recent advances in brain tumor diagnosis based on AI-based classification","volume":"13","author":"Kaifi","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"14","key":"10.1016\/bs.apcsb.2024.06.001_bib28","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1093\/nar\/29.14.2905","article-title":"Estrogen receptor interaction with estrogen response elements","volume":"29","author":"Klinge","year":"2001","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.06.001_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cellimm.2015.01.018","article-title":"Estrogen receptors regulate innate immune cells and signaling pathways","volume":"294","author":"Kovats","year":"2015","journal-title":"Cellular Immunology"},{"key":"10.1016\/bs.apcsb.2024.06.001_bib30","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/812540","article-title":"The dynamic structure of the estrogen receptor","volume":"2011","author":"Kumar","year":"2011","journal-title":"Journal of Amino Acids"},{"issue":"46","key":"10.1016\/bs.apcsb.2024.06.001_bib31","doi-asserted-by":"crossref","first-page":"81686","DOI":"10.18632\/oncotarget.20970","article-title":"Update on the therapeutic significance of estrogen receptor beta in malignant gliomas","volume":"8","author":"Lan","year":"2017","journal-title":"Oncotarget"},{"issue":"Pt 3","key":"10.1016\/bs.apcsb.2024.06.001_bib32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/BJ20050872","article-title":"Structure and function of steroid receptor AF1 transactivation domains: Induction of active conformations","volume":"391","author":"Lavery","year":"2005","journal-title":"The Biochemical Journal"},{"key":"10.1016\/bs.apcsb.2024.06.001_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.754196","article-title":"Targeting myeloid-derived suppressor cells to enhance the antitumor efficacy of immune checkpoint blockade therapy","volume":"12","author":"Li","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.06.001_bib34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.addr.2011.02.002","article-title":"Prodrugs for improving tumor targetability and efficiency","volume":"63","author":"Mahato","year":"2011","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/bs.apcsb.2024.06.001_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.587386","article-title":"Estrogen receptor bta (ERbeta): A ligand activated tumor suppressor","volume":"10","author":"Mal","year":"2020","journal-title":"Frontiers in Oncology"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.06.001_bib36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/mi.3.5.281","article-title":"Estrogen signaling: A subtle balance between ER alpha and ER beta","volume":"3","author":"Matthews","year":"2003","journal-title":"Molecular Interventions"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.06.001_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/1574884711308020006","article-title":"The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice","volume":"8","author":"Maximov","year":"2013","journal-title":"Current Clinical Pharmacology"},{"issue":"Suppl 1","key":"10.1016\/bs.apcsb.2024.06.001_bib38","first-page":"9","article-title":"Biomarker-driven oncology clinical trials: Novel designs in the era of precision medicine","volume":"14","author":"Moore","year":"2023","journal-title":"Journal of the Advanced Practitioner in Oncology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/clpt.2010.226","article-title":"Estrogen receptors: Therapies targeted to receptor subtypes","volume":"89","author":"Nilsson","year":"2011","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.06.001_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/187569208786733820","article-title":"Do estrogen receptor beta polymorphisms play A role in the pharmacogenetics of estrogen signaling?","volume":"6","author":"Nott","year":"2008","journal-title":"Current Pharmacogenomics and Personalized Medicine"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.06.001_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052529","article-title":"Glioblastoma therapy: Past, present and future","volume":"25","author":"Obrador","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2024.06.001_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.steroids.2014.06.012","article-title":"Estrogen receptors alpha (ERalpha) and beta (ERbeta): Subtype-selective ligands and clinical potential","volume":"90","author":"Paterni","year":"2014","journal-title":"Steroids"},{"issue":"12","key":"10.1016\/bs.apcsb.2024.06.001_bib43","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1021\/acs.bioconjchem.3c00446","article-title":"Brain-penetrating peptide shuttles across the blood-brain barrier and extracellular-like space","volume":"34","author":"Peng","year":"2023","journal-title":"Bioconjugate Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10799893.2013.853188","article-title":"Estrogen receptors (ERalpha versus ERbeta): Friends or foes in human biology?","volume":"34","author":"Planey","year":"2014","journal-title":"Journal of Receptor and Signal Transduction Research"},{"issue":"11","key":"10.1016\/bs.apcsb.2024.06.001_bib45","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1535-7163.MCT-23-0031","article-title":"Preclinical development of brain permeable ERbeta agonist for the treatment of glioblastoma.","volume":"22","author":"Pratap","year":"2023","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/bs.apcsb.2024.06.001_bib46","article-title":"Distribution and effects of estrogen receptors in prostate cancer: Associated molecular mechanisms","volume":"12","author":"Ramirez-de-Arellano","year":"2021","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.06.001_bib47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2217\/cns-2016-0010","article-title":"Psychosocial distress and its effects on the health-related quality of life of primary brain tumor patients","volume":"5","author":"Randazzo","year":"2016","journal-title":"CNS Oncology"},{"issue":"7","key":"10.1016\/bs.apcsb.2024.06.001_bib48","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/cmi.2017.129","article-title":"Roles of estrogens on myeloid-derived suppressor cells in cancer and autoimmune diseases","volume":"15","author":"Ren","year":"2018","journal-title":"Cellular & Molecular Immunology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.yfrne.2013.08.001","article-title":"Estrogen: A master regulator of bioenergetic systems in the brain and body","volume":"35","author":"Rettberg","year":"2014","journal-title":"Frontiers in Neuroendocrinology"},{"key":"10.1016\/bs.apcsb.2024.06.001_bib50","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3389\/fendo.2018.00610","article-title":"Cognitive effects of aromatase and possible role in memory disorders","volume":"9","author":"Rosenfeld","year":"2018","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.06.001_bib51","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s13311-019-00766-9","article-title":"The role of estrogen in brain and cognitive aging","volume":"16","author":"Russell","year":"2019","journal-title":"Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1574892812666171129142023","article-title":"Brain cancer: Implication to disease, therapeutic strategies and tumor targeted drug delivery approaches","volume":"13","author":"Shah","year":"2018","journal-title":"Recent Patents on Anti-Cancer Drug Discovery"},{"key":"10.1016\/bs.apcsb.2024.06.001_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1385577","article-title":"Next generation selective estrogen receptor degraders in postmenopausal women with advanced-stage hormone receptors-positive, HER2-negative breast cancer","volume":"14","author":"Sharaf","year":"2024","journal-title":"Frontiers in Oncology"},{"issue":"7","key":"10.1016\/bs.apcsb.2024.06.001_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25074130","article-title":"Estrogen alpha and beta receptor expression in the various regions of resected glioblastoma multiforme tumors and in an in vitro model","volume":"25","author":"Siminska","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib55","first-page":"17","article-title":"Mechanisms of temozolomide resistance in glioblastoma \u2013 A comprehensive review","volume":"4","author":"Singh","year":"2021","journal-title":"Cancer Drug Resistance"},{"issue":"15","key":"10.1016\/bs.apcsb.2024.06.001_bib56","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2174\/092986709788186093","article-title":"Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels","volume":"16","author":"Smiley","year":"2009","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2024.06.001_bib57","doi-asserted-by":"crossref","DOI":"10.1177\/09603271241256598","article-title":"Alkylating agents are possible inducers of glioblastoma and other brain tumors","volume":"43","author":"Smith","year":"2024","journal-title":"Human & Experimental Toxicology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib58","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11060-021-03902-8","article-title":"Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: Past, present and future developments","volume":"156","author":"Soler","year":"2022","journal-title":"Journal of Neuro-oncology"},{"issue":"11","key":"10.1016\/bs.apcsb.2024.06.001_bib59","article-title":"Molecular proof of a clinical concept: Expression of estrogen alpha-, beta-receptors and G protein-coupled estrogen receptor 1 (GPER) in histologically assessed common nevi, dysplastic nevi and melanomas","volume":"57","author":"Spalkowska","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.06.001_bib60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.14715\/cmb\/2024.70.5.34","article-title":"Research progress on function and mechanism of long non-coding RNA in glioma","volume":"70","author":"Tai","year":"2024","journal-title":"Cellular and Molecular Biology (Noisy-le-grand)"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41392-023-01651-w","article-title":"Transcriptional co-activators: Emerging roles in signaling pathways and potential therapeutic targets for diseases","volume":"8","author":"Talukdar","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.06.001_bib62","doi-asserted-by":"crossref","first-page":"481","DOI":"10.6061\/clinics\/2016(08)12","article-title":"Expression of estrogen and progesterone receptors in astrocytomas: A literature review","volume":"71","author":"Tavares","year":"2016","journal-title":"Clinics (Sao Paulo)"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.06.001_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040269","article-title":"Blood-brain delivery methods using nanotechnology","volume":"10","author":"Teleanu","year":"2018","journal-title":"Pharmaceutics"},{"issue":"22","key":"10.1016\/bs.apcsb.2024.06.001_bib64","first-page":"8037","article-title":"Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens","volume":"63","author":"Thiantanawat","year":"2003","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.06.001_bib65","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4103\/ajns.AJNS_39_15","article-title":"Tumor recurrence in a glioblastoma patient after discontinuation of prolonged temozolomide treatment","volume":"12","author":"Tseng","year":"2017","journal-title":"Asian Journal of Neurosurgery"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.06.001_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ph16030433","article-title":"Exploring the application of micellar drug delivery systems in cancer nanomedicine","volume":"16","author":"Wang","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.06.001_bib67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1208\/s12249-021-01928-9","article-title":"Enhancement of therapies for glioblastoma (GBM) using nanoparticle-based delivery systems","volume":"22","author":"Wiwatchaitawee","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.06.001_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044043","article-title":"Emerging evidence on membrane estrogen receptors as novel therapeutic targets for central nervous system pathologies","volume":"24","author":"Wnuk","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/rmb2.12006","article-title":"Molecular mechanism of estrogen-estrogen receptor signaling","volume":"16","author":"Yasar","year":"2017","journal-title":"Reproductive Medicine and Biology"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.06.001_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020248","article-title":"Systemic and local strategies for primary prevention of breast cancer","volume":"16","author":"Zaluzec","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.06.001_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030830","article-title":"Exploring the past, present, and future of anti-angiogenic therapy in glioblastoma","volume":"15","author":"Zhang","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.06.001_bib72","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1038\/s41598-019-42313-8","article-title":"Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways","volume":"9","author":"Zhou","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2024.06.001_bib73","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231199359","article-title":"Role of estrogen in the regulation of central and peripheral energy homeostasis: From a menopausal perspective","volume":"14","author":"Zhu","year":"2023","journal-title":"Therapeutic Advances in Endocrinology and Metabolism"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162324000506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162324000506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T06:09:12Z","timestamp":1721887752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162324000506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443193460"],"references-count":73,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2024.06.001","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}